June 6, 2022 – Caresfield LLC, a U.S.-based manufacturer and distributor of healthcare consumable products, is pleased to support the Cancer Research Institute (CRI) as a sponsor of Cancer Immunotherapy Month in June as part of the Caresfield Cares Program. CRI is a 501(c)(3) nonprofit organization funding immunotherapy research.
Caresfield CEO Ron Griffith is pleased to support CRI in this initiative because of how it aligns with Caresfield’s core values to work with a purpose and commit to caring.
“A number of our team members have been personally affected by cancer,” Griffith said. “As a company, Caresfield provides consumable products that help in the diagnosis and treatment of cancer, from the chemotherapy drug-rated nitrile exam gloves that clinicians wear to the healthcare labels that are used in specimen identification. By supporting Cancer Research Institute’s important purpose, we hope to help patients have the best chance for a longer life.”
“Caresfield and its employees are helping to transform the future of cancer treatment through their support of the Cancer Research Institute and our mission to save more lives by funding the most promising cancer immunotherapy research anywhere in the world,” said Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs at the Cancer Research Institute. “During Cancer Immunotherapy Month in June, CRI celebrates Caresfield and all our partners who have joined us in spreading awareness of this revolutionary new way to treat—and one day potentially cure—all cancers.”